Ulihope is a newer potential therapeutic option at Urihk pharmaceutical company in india.
Ulihope - 100000 IU Injection is a Lyophilized powder for injection used for the treatment of severe sepsis and mild to severe acute pancreatitis. This medicine is used for severe sepsis and acute pancreatitis treatment for critically ill patients. Sepsis - a serious complication of an infection and other medical conditions. Acute pancreatitis - patient suffering from a mild-to-severe acute pancreatitis, which is a sudden inflammation of the pancreas. Ulinastatin is a urinary  trypsin inhibitor, is considered as a potentially beneficial immunomodulator drug for multiple  organ  dysfunction  syndrome  (MODS). The preliminary data revealed that high dose of ulinastatin treatment was safe and showed a potential beneficial effect for patients with Covid-19.Â
